OverdoseFreePA Archive and Events

Search through previously posted articles, reports, events, and blog posts.

Upcoming Events

Blog Posts

Overdose Survivors in the ER: Seizing Opportunity within Tragedy

Hospital emergency rooms (ER) across the state are working to realize the potential for opportunity ...

Fentanyl

Across Pennsylvania, heroin, pharmaceuticals, and other illicit drug use continues to increase leadi...

PA DHS Centers of Excellence

Pennsylvania leads the nation in the number of drug overdoses in men ages 12-25 and eighth among the...

Recovery & Stigma

Society stigmatizes addicts as bad people that make a choice to become addicted. When I was a lit...

Everybody Matters

As many of you can tell from the recent news articles, social media, and perhaps your own life exp...

OverdoseFreePA Archive and Events

Search through previously posted articles, reports, events, and blog posts.

Archive

Gabapentin Background Report

Methamphetamine Background Report

2018 Regional Pennsylvania Stimulant Reports

2018 Pennsylvania Stimulant Report

ACOPC: 2019 Summer Conference Presentations

Medication-Assisted Treatment of Opioid Use Disorder

Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care- Outcomes During and After Intervention

Methadone Deaths- Risk Factors in Pain and Addicted Populations

Buprenorphine Maintenance versus Placebo or Methadone: Maintenance for Opioid Dependence (Review)

Self-treatment: Illicit Buprenorphine Use by Opioid-Dependent Treatment Seekers

Tapering Toolkit Provider Resource

TIP 63 Medications for Opioid Use Disorder: Executive Summary

Federal Regulation of Methadone Treatment

Heroin-Dependent Inmates’ Experiences with Buprenorphine or Methadone Maintenance

Release from Prison — A High Risk of Death for Former Inmates

Jail Management of Arrestees/Inmates Enrolled in Community Methadone Maintenance Programs

Medication-Assisted Treatment in Criminal Justice Agencies Affiliated with the Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS): Availability, Barriers & Intentions

Medication Assisted Treatment Research with Criminal Justice Populations: Challenges of Implementation

Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System

A National Case-Control Study of Risk Factors Among Prisoners in England and Wales

Buprenorphine-Naloxone Maintenance Following Release from Jail

Buprenorphine and Methadone Maintenance in Jail and Post-Release: A Randomized Clinical Trial

Does Exposure to Opioid Substitution Treatment in Prison Reduce the Risk of Death after Release? A National Prospective Observational Study in England

The Effect of a Jail Methadone Maintenance Therapy (MMT) Program on Inmate Recidivism

Meta-Analysis of Drug-Related Deaths Soon After Release from Prison

A Typology of Male Prisoners Making Near-Lethal Suicide Attempts

State of the Art and Science: Why It’s Inappropriate Not to Treat Incarcerated Patients with Opioid Agonist Therapy

Safety of the Newer Class of Opioid Antagonists in Pregnancy

Buprenorphine Compared with Methadone to Treat Pregnant Women with Opioid Use Disorder-A Systematic Review and Meta-analysis of Safety in the Mother, Fetus, and Child

Decision Science can Help Policymakers to Identify and Evaluate Policies to Treat Opioid Use Disorder Among Pregnant Women

Maintenance Agonist Treatments for Opiate-Dependent Pregnant Women

Infants of Opioid-Dependent Mothers-Neurodevelopment at Six Months

Methadone Versus Buprenorphine for Opioid Use Dependence and Risk of Neonatal Abstinence Syndrome

Treatment of Opioid-Dependent Pregnant Women-Clinical and Research Issues

Clinical Care for Opioid-Using Pregnant and Postpartum Women

A Review of Recent Findings on Substance Abuse Treatment for Pregnant Women

Using Behavioral Economic Theory to Increase Use of Effective Contraceptives among Opioid-Maintained Women at Risk of Unintended Pregnancy

Management of Women Treated with Buprenorphine During Pregnancy

State and Local Policy Levers for Increasing Treatment and Recovery Capacity to Address the Opioid Epidemic

Fentanyl Drug Facts

Pennsylvania Youth State Survey Report 2017

DEA: Legal cases against doctors

The Underestimated Cost of the Opioid Crisis

The Economic Cost of the Opioid Epidemic in Pennsylvania

SAMHSA Opioid Overdose Prevention Toolkit

The National Practice Guidelines for the Use of Medications in the Treatment of Addiction Involving Opioid Use

Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health

Access to Substance Use Disorder Treatment in Medicaid

Evidence Based Strategies for Preventing Opioid Overdose: What’s Working in the United States

Neonatal and Maternal Hospitalizations related to substance misuse

Pennsylvania Drug and Alcohol Annual Plan and Report 2015-2016

Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas

Drug Overdose Deaths in the United States, 1999-2006

CDC: 2018 Annual Surveillance Report of Drug-Related Risks and Outcomes

CDC: 2017 Annual Surveillance Report of Drug-Related Risks and Outcomes

International Narcotics Control Strategy Report

Public Opinion of Prescription Drug Abuse and Disposal

The Health and Social Effects of Nonmedical Cannabis Use

Neuroscience of Psychoactive Substance Use and Dependence

Drugs, Brains, and Behavior: The Science of Addiction

Drug-Related Overdose Deaths in Pennsylvania, 2018: A Joint Report with the Drug Enforcement Administration and University of Pittsburgh School of Pharmacy

ACOPC: 2017 Summer Conference Presentations

ACOPC: 2018 Summer Conference Presentations

DEA: Carfentanil in Pennsylvania

DEA: Cocaine/Fentanyl Combination in Pennsylvania

DEA: Drug Presence in Pennsylvania 1999-2016

PA Stop: Five Questions with Jamie Drake

Prehospital Opioid Safety

Statewide Database Helps Track Overdose Deaths in Pennsylvania

DEA: 2017 National Drug Threat Assessment

Are People Really Falling ill from Touching Fentanyl? ACMT and AACT Position Statement.

DEA: Emerging Threat Report

Naloxone Information Sheet